Latest Views & News

Akers Biosciences – “decided to withdraw” an initial FDA application… & worse

By Tom Winnifrith & Steve Moore | Wednesday 30 May 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


A slump in shares in Akers Biosciences (AKR & NASDAQ - AKER) was noted in Bearcast yesterday, what’s the detail?...

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

|